Header Logo

Connection

LAURA MARSH to Female

Back to Details
This is a "connection" page, showing publications LAURA MARSH has written about Female.
LAURA MARSH
Connection Strength
0.214
Female
  1. Pharmacologic treatment of anxiety disorders in Parkinson disease. Am J Geriatr Psychiatry. 2013 Jun; 21(6):520-8.
    View in: PubMed
    Score: 0.013
  2. Improving detection of psychiatric disturbances in Parkinson's disease: the role of informants. J Parkinsons Dis. 2013; 3(1):55-60.
    View in: PubMed
    Score: 0.013
  3. Application of depression rating scales in patients with Parkinson's disease with and without co-Occurring anxiety. J Parkinsons Dis. 2013; 3(4):603-8.
    View in: PubMed
    Score: 0.013
  4. Prevalence of psychotic symptoms in a community-based Parkinson disease sample. Am J Geriatr Psychiatry. 2012 Feb; 20(2):123-32.
    View in: PubMed
    Score: 0.012
  5. Familial aggregation of panic disturbances in Parkinson's disease. J Neuropsychiatry Clin Neurosci. 2011; 23(4):417-24.
    View in: PubMed
    Score: 0.011
  6. Prevalence of anxiety disorders and anxiety subtypes in patients with Parkinson's disease. Mov Disord. 2009 Jul 15; 24(9):1333-8.
    View in: PubMed
    Score: 0.010
  7. Validity of the Cornell scale for depression in dementia in Parkinson's disease with and without cognitive impairment. Mov Disord. 2009 Feb 15; 24(3):433-7.
    View in: PubMed
    Score: 0.010
  8. Atomoxetine for the treatment of executive dysfunction in Parkinson's disease: a pilot open-label study. Mov Disord. 2009 Jan 30; 24(2):277-82.
    View in: PubMed
    Score: 0.010
  9. Randomized placebo-controlled trial of donepezil in cognitive impairment in Parkinson's disease. Int J Geriatr Psychiatry. 2004 Jan; 19(1):1-8.
    View in: PubMed
    Score: 0.007
  10. Dystonia and Tremor: A Cross-Sectional Study of the Dystonia Coalition Cohort. Neurology. 2021 01 26; 96(4):e563-e574.
    View in: PubMed
    Score: 0.005
  11. Accuracy of the PHQ-2 Alone and in Combination With the PHQ-9 for Screening to Detect Major Depression: Systematic Review and Meta-analysis. JAMA. 2020 06 09; 323(22):2290-2300.
    View in: PubMed
    Score: 0.005
  12. Post-Traumatic Stress Disorder is Associated with further Increased Parkinson's Disease Risk in Veterans with Traumatic Brain Injury. Ann Neurol. 2020 07; 88(1):33-41.
    View in: PubMed
    Score: 0.005
  13. Patient Health Questionnaire-9 scores do not accurately estimate depression prevalence: individual participant data meta-analysis. J Clin Epidemiol. 2020 06; 122:115-128.e1.
    View in: PubMed
    Score: 0.005
  14. Probability of major depression diagnostic classification using semi-structured versus fully structured diagnostic interviews. Br J Psychiatry. 2018 06; 212(6):377-385.
    View in: PubMed
    Score: 0.005
  15. Cervical dystonia and substance abuse. J Neurol. 2018 Apr; 265(4):970-975.
    View in: PubMed
    Score: 0.005
  16. Perceived Treatment Status of Fluctuations in Parkinson Disease Impacts Suicidality. Am J Geriatr Psychiatry. 2018 06; 26(6):700-710.
    View in: PubMed
    Score: 0.004
  17. Psychiatric associations of adult-onset focal dystonia phenotypes. J Neurol Neurosurg Psychiatry. 2017 07; 88(7):595-602.
    View in: PubMed
    Score: 0.004
  18. Active Mental Illnesses Adversely Affect Surgical Outcomes. Am Surg. 2016 Dec 01; 82(12):1238-1243.
    View in: PubMed
    Score: 0.004
  19. Factors Associated With Veterans' Access to Permanent Supportive Housing. Psychiatr Serv. 2016 08 01; 67(8):870-7.
    View in: PubMed
    Score: 0.004
  20. Modeling anxiety in Parkinson's disease. Mov Disord. 2016 Mar; 31(3):310-6.
    View in: PubMed
    Score: 0.004
  21. The longitudinal impact of depression on disability in Parkinson disease. Int J Geriatr Psychiatry. 2016 May; 31(5):458-65.
    View in: PubMed
    Score: 0.004
  22. Influence of schizophrenia diagnosis on providers' practice decisions. J Clin Psychiatry. 2015 Aug; 76(8):1068-74; quiz 1074.
    View in: PubMed
    Score: 0.004
  23. A Pilot Study of a Cognitive-Behavioral Treatment for Anxiety and Depression in Patients With Parkinson Disease. J Geriatr Psychiatry Neurol. 2015 Sep; 28(3):210-7.
    View in: PubMed
    Score: 0.004
  24. Mental health diagnoses and health care utilization in persons with dementia, Parkinson's disease, and stroke. J Neuropsychiatry Clin Neurosci. 2015; 27(2):e117-21.
    View in: PubMed
    Score: 0.004
  25. Alleviating manoeuvres (sensory tricks) in cervical dystonia. J Neurol Neurosurg Psychiatry. 2014 Aug; 85(8):882-4.
    View in: PubMed
    Score: 0.003
  26. Cognitive and motor function in long-duration PARKIN-associated Parkinson disease. JAMA Neurol. 2014 Jan; 71(1):62-7.
    View in: PubMed
    Score: 0.003
  27. Anxiety has specific syndromal profiles in Parkinson disease: a data-driven approach. Am J Geriatr Psychiatry. 2014 Dec; 22(12):1410-7.
    View in: PubMed
    Score: 0.003
  28. Modeling depression in Parkinson disease: disease-specific and nonspecific risk factors. Neurology. 2013 Sep 17; 81(12):1036-43.
    View in: PubMed
    Score: 0.003
  29. Rasch analysis of anxiety scales in Parkinson's disease. J Psychosom Res. 2013 May; 74(5):414-9.
    View in: PubMed
    Score: 0.003
  30. Cognitive behavioral therapy for depression and anxiety in Parkinson's disease: a clinical review. J Parkinsons Dis. 2012; 2(2):135-51.
    View in: PubMed
    Score: 0.003
  31. Ocular motor and sensory function in Parkinson's disease. Ophthalmology. 2012 Jan; 119(1):178-82.
    View in: PubMed
    Score: 0.003
  32. Anxiety rating scales in Parkinson's disease: a validation study of the Hamilton anxiety rating scale, the Beck anxiety inventory, and the hospital anxiety and depression scale. Mov Disord. 2011 Feb 15; 26(3):407-15.
    View in: PubMed
    Score: 0.003
  33. Symptomatology and markers of anxiety disorders in Parkinson's disease: a cross-sectional study. Mov Disord. 2011 Feb 15; 26(3):484-92.
    View in: PubMed
    Score: 0.003
  34. Neuropsychological Profile of Parkin Mutation Carriers with and without Parkinson Disease: The CORE-PD Study. J Int Neuropsychol Soc. 2011 Jan; 17(1):91-100.
    View in: PubMed
    Score: 0.003
  35. Frequency of known mutations in early-onset Parkinson disease: implication for genetic counseling: the consortium on risk for early onset Parkinson disease study. Arch Neurol. 2010 Sep; 67(9):1116-22.
    View in: PubMed
    Score: 0.003
  36. Co-existence of Parkinson's disease and progressive supranuclear palsy: case report and a review of the literature. Neurol Sci. 2011 Feb; 32(1):159-63.
    View in: PubMed
    Score: 0.003
  37. Predictors of parkin mutations in early-onset Parkinson disease: the consortium on risk for early-onset Parkinson disease study. Arch Neurol. 2010 Jun; 67(6):731-8.
    View in: PubMed
    Score: 0.003
  38. Motor phenotype of LRRK2 G2019S carriers in early-onset Parkinson disease. Arch Neurol. 2009 Dec; 66(12):1517-22.
    View in: PubMed
    Score: 0.003
  39. The course of depressive symptoms in early Parkinson's disease. Mov Disord. 2009 Jul 15; 24(9):1306-11.
    View in: PubMed
    Score: 0.002
  40. Morphometry of the human substantia nigra in ageing and Parkinson's disease. Acta Neuropathol. 2008 Apr; 115(4):461-70.
    View in: PubMed
    Score: 0.002
  41. Alpha-synuclein and Parkinson's disease: implications from the screening of more than 1,900 patients. Mov Disord. 2005 Sep; 20(9):1191-4.
    View in: PubMed
    Score: 0.002
  42. Abeta deposition is associated with enhanced cortical alpha-synuclein lesions in Lewy body diseases. Neurobiol Aging. 2005 Aug-Sep; 26(8):1183-92.
    View in: PubMed
    Score: 0.002
  43. Psychopathology in patients with degenerative cerebellar diseases: a comparison to Huntington's disease. Am J Psychiatry. 2002 Aug; 159(8):1306-14.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.